Li, Y. and Zhou, B. (2025) Research Progress on the Relationship between Dynapenic Obesity and Type 2 Diabetes. Journal of Biosciences and Medicines, 13, 256-267. doi: 10.4236/jbm.2025.132020 .

Types of cell signalling pathways include checkpoint signalling, lipid signalling, growth signalling, nutrient signalling, insulin signalling ... of vascular smooth muscle cells, extracellular ...

Apoptosis or programmed cell death (PCD) is a physiological process critical for organ development, tissue homeostasis and elimination of defective or potentially dangerous cells in complex organisms.

The kidney is a complex organ comprising various functional partitions and special cell types that play important roles in maintaining homeostasis in the body. Diabetic kidney disease (DKD) is the ...

Neurons are cells in the body that are responsible for transmitting electrical signals through ... and control the movement of the body. These neurons coordinate muscle activity. Motor neurons can be ...

In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest ...

Static stretching and muscle growth caused a stir in bodybuilding circles last year when a study compared a stretching protocol to resistance training, and found those in the stretching group ...

(ABC 6 News) – On Monday, Attorney General Keith Ellison announced a settlement with Novo Nordisk that let’s Minnesotans buy its insulin products for $35 per month. For the next five years ...

ST. PAUL, Minn. — Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable ...

The Minnesota Attorney General's Office announced a settlement has been reached with manufacturer Novo Nordisk over the high cost of insulin. The AG's office filed a lawsuit in 2018 against ...